|
Sorted by: Date | Top Results
|
|
Author |
|
Date |
| |
| |
| 1. |
Re: Yeah, too bad Blobel gave away $1.00 of share price 
We all would rather have the $6. Just unnecessary.
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
SciClone Pharmaceuticals, Inc.
|
|
a65232389 |
|
19-Dec-09 08:23 pm |
| |
| 2. |
Re: Yeah, too bad Blobel gave away $1.00 of share price
I agree, the stock should be trading on a P/E basis.
That means every penny of earnings matters and $.06
per share at 16x is $1.00 in stock market value. That's
what I figure Blobel...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
SciClone Pharmaceuticals, Inc.
|
|
a65232389 |
|
19-Dec-09 05:18 pm |
| |
| 3. |
Re: H1N1 pricing and reimbursement
Let's wait for the results from the current trial.
They should be coming soon, then we'll have a
better idea of how well the Zad shots work. The press
release says the primary...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
SciClone Pharmaceuticals, Inc.
|
|
a65232389 |
|
3-Dec-09 05:39 pm |
| |
| 4. |
Re: H1N1 pricing and reimbursement
I was just using the figures in the elderly patients
studies. Out of every 100 patients, the vaccine alone
was successful in 35 patients. For...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
SciClone Pharmaceuticals, Inc.
|
|
a65232389 |
|
2-Dec-09 06:58 pm |
| |
| 5. |
Re: H1N1 pricing and reimbursement
Zadaxin is approved only in Italy, not in any other
EU country. Reimbursement will be key. ST sees the
H1N1 situation as an opportunity to try to get "emergency"
approval for these high-risk...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
SciClone Pharmaceuticals, Inc.
|
|
a65232389 |
|
2-Dec-09 05:50 pm |
| |
| 6. |
Re: Be careful out there
You're right, ST has to get a reimbursement price.
Anyone know what the reimbursement price is for the
1.6mg shot already approved in Italy?
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
SciClone Pharmaceuticals, Inc.
|
|
a65232389 |
|
30-Nov-09 08:51 pm |
| |
| 7. |
Re: Be careful out there
They got it right that they have to get this down to
two shots. To do this they have loaded up the dosage.
The old studies were 1.6mg shots. The ones in this
trial...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
SciClone Pharmaceuticals, Inc.
|
|
a65232389 |
|
30-Nov-09 08:37 pm |
| |
| 8. |
Re: Sigma Tau and SCLN management
Sigma-Tau is in the driver's seat. ST stands to
gain from a positive H1N1 trial in Italy. As Blobel
said in the cc, all sales would be according to the
2000 agreement with ST...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
SciClone Pharmaceuticals, Inc.
|
|
a65232389 |
|
30-Nov-09 04:01 pm |
| |
| 9. |
H1N1 and Zadaxin&&39;s future
In the quarterly results conference call Blobel said
the Sigma-Tau relationship follows the 2000 agreement
between the two companies. Digging into the SEC filings,
the...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
SciClone Pharmaceuticals, Inc.
|
|
a65232389 |
|
20-Nov-09 06:18 pm |
| |
| 10. |
Re: Employees selling out big
It's not news, just an observation. Employees selling
out is not a buy signal. If there was little option
exercise in the quarter, that would have been a buy
signal...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
SciClone Pharmaceuticals, Inc.
|
|
a65232389 |
|
17-Nov-09 07:36 pm |
| |
| 11. |
Employees selling out big
Don't count on any SciClone buying action. It looks
like SciClone employees took advantage of the price
run up to exercise and sell 70-80% of all of their
in-the-money exercisable...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
SciClone Pharmaceuticals, Inc.
|
|
a65232389 |
|
17-Nov-09 05:57 pm |
| |
| 12. |
Re: 10Q
Good insight. I have no doubt that SciClone has a solid
business in China. The problem is how management sucks
the blood out of it. Despite a "modest"
price increase and higher...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
SciClone Pharmaceuticals, Inc.
|
|
a65232389 |
|
15-Nov-09 07:07 pm |
| |
| 13. |
Re: sigma tau bought a biotech enzn
Stock prices are also affected by a company's acquisition
potential. That's been a significant factor for
a while now in the pharmaceutical sector - "who's
next?" A 20% owner should be...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
SciClone Pharmaceuticals, Inc.
|
|
a65232389 |
|
9-Nov-09 08:27 pm |
| |
| 14. |
Re: sigma tau bought a biotech enzn
If you want to see at least $5 on a buyout, then S-T
would have to pay $200 million for the SCLN shares
it doesn't already own. The observation is that
anything like $200 million would look like a stre
tch...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
SciClone Pharmaceuticals, Inc.
|
|
a65232389 |
|
9-Nov-09 08:08 pm |
| |
| 15. |
Re: sigma tau bought a biotech enzn
$300 million is a big deal for S-T. Doubt they would
be doing anything else big for some time, so this
probably takes them out for being a potential buyer
of SCLN anytime soon.
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
SciClone Pharmaceuticals, Inc.
|
|
a65232389 |
|
9-Nov-09 07:32 pm |
| |
| 16. |
"They Shoot Government Officials, Don&&39;t They?"
The filing of a beefed-up Code of Ethics raises concerns.
Checking the web sites of other companies where S-T
sits on the board...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
SciClone Pharmaceuticals, Inc.
|
|
a65232389 |
|
7-Nov-09 05:05 pm |
| |
| 17. |
Re: BioWorld Today
The melanoma data has been out for two years now. Between
the company and S-T they must have done a thorough
job of looking for a partner but with no takers. My
guess...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
SciClone Pharmaceuticals, Inc.
|
|
a65232389 |
|
6-Nov-09 08:00 pm |
| |
| 18. |
Re: Bribery? Todays&&39; news
This is serious stuff. Remember two years ago the head
of the SFDA in China was executed for accepting bribes.
Don't know what happened to the folks...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
SciClone Pharmaceuticals, Inc.
|
|
a65232389 |
|
6-Nov-09 07:20 pm |
| |
| 19. |
Re: BioWorld Today
Maybe they are bringing back Sellers! Seriously, they
should get a CEO who knows something about marketing
in China since that's pretty much what SciClone
has...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
SciClone Pharmaceuticals, Inc.
|
|
a65232389 |
|
5-Nov-09 03:03 pm |
| |
| 20. |
Re: Roche Melanoma News
Maybe a melanoma partnership would have meant something
before the BOD gave away the rights to Sigma Tau.
This has been bugging me for a while. SciClone...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
SciClone Pharmaceuticals, Inc.
|
|
a65232389 |
|
24-Sep-09 06:45 pm |
| |